Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome: Preferential recognition of the major phospholipid-binding site

Takahide Arai, Kazue Yoshida, Junichi Kaburaki, Hidetoshi Inoko, Yasuo Ikeda, Yutaka Kawakami, Masataka Kuwana

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Autoreactive CD4+ T cells to β2-glycoprotein I (β2GPI) that promote antiphospholipid antibody production were recently identified in patients with antiphospholipid syndrome (APS). To further examine antigen recognition profiles and T-cell helper activity in β2GPI-reactive T cells, 14 CD4+ T-cell clones specific to β2GPI were generated from 3 patients with APS by repeated stimulation of peripheral blood T cells with recombinant β2GPI. At least 4 distinct T-cell epitopes were identified, but the majority of the β2GPI-specific T-cell clones responded to a peptide encompassing amino acid residues 276 to 290 of β2GPI (KVSFFCKNKEKKCSY; single-letter amino acid codes) that contains the major phospholipid-binding site in the context of the DRB4*0103 allele. Ten of 12 β2GPI-specific T-cell clones were able to stimulate autologous peripheral blood B cells to promote anti-β2GPI antibody production in the presence of recombinant β2GPI. T-cell helper activity was exclusively found in T-cell clones capable of producing interleukin 6 (IL-6). In vitro anti-β2GPI antibody production induced by T-cell clones was inhibited by anti-IL-6 or anti-CD40 ligand monoclonal antibody. In addition, exogenous IL-6 augmented anti-β2GPI antibody production in cultures of the T-cell clone lacking IL-6 expression. These results indicate that β2GPI-specific CD4+ T cells in patients with APS preferentially recognize the antigenic peptide containing the major phospholipid-binding site and have the capacity to stimulate B cells to produce antiβ2GPI antibodies through IL-6 expression and CD40-CD40 ligand engagement. These findings are potentially useful for clarifying the pathogenesis of APS and for developing therapeutic strategies that suppress pathogenic antiphospholipid antibody production in these patients.

Original languageEnglish
Pages (from-to)1889-1896
Number of pages8
JournalBlood
Volume98
Issue number6
DOIs
Publication statusPublished - 2001 Sep 15

Fingerprint

Antiphospholipid Syndrome
T-cells
Phospholipids
Glycoproteins
Clone Cells
Binding Sites
T-Lymphocytes
Antibody Formation
Interleukin-6
CD40 Ligand
Antiphospholipid Antibodies
Antibodies
Helper-Inducer T-Lymphocytes
Blood Cells
Blood
B-Lymphocytes
Cells
Amino Acids
Peptides
T-Lymphocyte Epitopes

ASJC Scopus subject areas

  • Hematology

Cite this

Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome : Preferential recognition of the major phospholipid-binding site. / Arai, Takahide; Yoshida, Kazue; Kaburaki, Junichi; Inoko, Hidetoshi; Ikeda, Yasuo; Kawakami, Yutaka; Kuwana, Masataka.

In: Blood, Vol. 98, No. 6, 15.09.2001, p. 1889-1896.

Research output: Contribution to journalArticle

Arai, Takahide ; Yoshida, Kazue ; Kaburaki, Junichi ; Inoko, Hidetoshi ; Ikeda, Yasuo ; Kawakami, Yutaka ; Kuwana, Masataka. / Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome : Preferential recognition of the major phospholipid-binding site. In: Blood. 2001 ; Vol. 98, No. 6. pp. 1889-1896.
@article{6e8f150db88144968f7982706c3e4127,
title = "Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome: Preferential recognition of the major phospholipid-binding site",
abstract = "Autoreactive CD4+ T cells to β2-glycoprotein I (β2GPI) that promote antiphospholipid antibody production were recently identified in patients with antiphospholipid syndrome (APS). To further examine antigen recognition profiles and T-cell helper activity in β2GPI-reactive T cells, 14 CD4+ T-cell clones specific to β2GPI were generated from 3 patients with APS by repeated stimulation of peripheral blood T cells with recombinant β2GPI. At least 4 distinct T-cell epitopes were identified, but the majority of the β2GPI-specific T-cell clones responded to a peptide encompassing amino acid residues 276 to 290 of β2GPI (KVSFFCKNKEKKCSY; single-letter amino acid codes) that contains the major phospholipid-binding site in the context of the DRB4*0103 allele. Ten of 12 β2GPI-specific T-cell clones were able to stimulate autologous peripheral blood B cells to promote anti-β2GPI antibody production in the presence of recombinant β2GPI. T-cell helper activity was exclusively found in T-cell clones capable of producing interleukin 6 (IL-6). In vitro anti-β2GPI antibody production induced by T-cell clones was inhibited by anti-IL-6 or anti-CD40 ligand monoclonal antibody. In addition, exogenous IL-6 augmented anti-β2GPI antibody production in cultures of the T-cell clone lacking IL-6 expression. These results indicate that β2GPI-specific CD4+ T cells in patients with APS preferentially recognize the antigenic peptide containing the major phospholipid-binding site and have the capacity to stimulate B cells to produce antiβ2GPI antibodies through IL-6 expression and CD40-CD40 ligand engagement. These findings are potentially useful for clarifying the pathogenesis of APS and for developing therapeutic strategies that suppress pathogenic antiphospholipid antibody production in these patients.",
author = "Takahide Arai and Kazue Yoshida and Junichi Kaburaki and Hidetoshi Inoko and Yasuo Ikeda and Yutaka Kawakami and Masataka Kuwana",
year = "2001",
month = "9",
day = "15",
doi = "10.1182/blood.V98.6.1889",
language = "English",
volume = "98",
pages = "1889--1896",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome

T2 - Preferential recognition of the major phospholipid-binding site

AU - Arai, Takahide

AU - Yoshida, Kazue

AU - Kaburaki, Junichi

AU - Inoko, Hidetoshi

AU - Ikeda, Yasuo

AU - Kawakami, Yutaka

AU - Kuwana, Masataka

PY - 2001/9/15

Y1 - 2001/9/15

N2 - Autoreactive CD4+ T cells to β2-glycoprotein I (β2GPI) that promote antiphospholipid antibody production were recently identified in patients with antiphospholipid syndrome (APS). To further examine antigen recognition profiles and T-cell helper activity in β2GPI-reactive T cells, 14 CD4+ T-cell clones specific to β2GPI were generated from 3 patients with APS by repeated stimulation of peripheral blood T cells with recombinant β2GPI. At least 4 distinct T-cell epitopes were identified, but the majority of the β2GPI-specific T-cell clones responded to a peptide encompassing amino acid residues 276 to 290 of β2GPI (KVSFFCKNKEKKCSY; single-letter amino acid codes) that contains the major phospholipid-binding site in the context of the DRB4*0103 allele. Ten of 12 β2GPI-specific T-cell clones were able to stimulate autologous peripheral blood B cells to promote anti-β2GPI antibody production in the presence of recombinant β2GPI. T-cell helper activity was exclusively found in T-cell clones capable of producing interleukin 6 (IL-6). In vitro anti-β2GPI antibody production induced by T-cell clones was inhibited by anti-IL-6 or anti-CD40 ligand monoclonal antibody. In addition, exogenous IL-6 augmented anti-β2GPI antibody production in cultures of the T-cell clone lacking IL-6 expression. These results indicate that β2GPI-specific CD4+ T cells in patients with APS preferentially recognize the antigenic peptide containing the major phospholipid-binding site and have the capacity to stimulate B cells to produce antiβ2GPI antibodies through IL-6 expression and CD40-CD40 ligand engagement. These findings are potentially useful for clarifying the pathogenesis of APS and for developing therapeutic strategies that suppress pathogenic antiphospholipid antibody production in these patients.

AB - Autoreactive CD4+ T cells to β2-glycoprotein I (β2GPI) that promote antiphospholipid antibody production were recently identified in patients with antiphospholipid syndrome (APS). To further examine antigen recognition profiles and T-cell helper activity in β2GPI-reactive T cells, 14 CD4+ T-cell clones specific to β2GPI were generated from 3 patients with APS by repeated stimulation of peripheral blood T cells with recombinant β2GPI. At least 4 distinct T-cell epitopes were identified, but the majority of the β2GPI-specific T-cell clones responded to a peptide encompassing amino acid residues 276 to 290 of β2GPI (KVSFFCKNKEKKCSY; single-letter amino acid codes) that contains the major phospholipid-binding site in the context of the DRB4*0103 allele. Ten of 12 β2GPI-specific T-cell clones were able to stimulate autologous peripheral blood B cells to promote anti-β2GPI antibody production in the presence of recombinant β2GPI. T-cell helper activity was exclusively found in T-cell clones capable of producing interleukin 6 (IL-6). In vitro anti-β2GPI antibody production induced by T-cell clones was inhibited by anti-IL-6 or anti-CD40 ligand monoclonal antibody. In addition, exogenous IL-6 augmented anti-β2GPI antibody production in cultures of the T-cell clone lacking IL-6 expression. These results indicate that β2GPI-specific CD4+ T cells in patients with APS preferentially recognize the antigenic peptide containing the major phospholipid-binding site and have the capacity to stimulate B cells to produce antiβ2GPI antibodies through IL-6 expression and CD40-CD40 ligand engagement. These findings are potentially useful for clarifying the pathogenesis of APS and for developing therapeutic strategies that suppress pathogenic antiphospholipid antibody production in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0035885939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035885939&partnerID=8YFLogxK

U2 - 10.1182/blood.V98.6.1889

DO - 10.1182/blood.V98.6.1889

M3 - Article

C2 - 11535526

AN - SCOPUS:0035885939

VL - 98

SP - 1889

EP - 1896

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -